Maia Biotechnology Stock Probability of Future Stock Price Finishing Over 15.86
| MAIA Stock | USD 2.20 0.04 1.85% |
MAIA |
MAIA Biotechnology Target Price Odds to finish over 15.86
The tendency of MAIA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 15.86 or more in 90 days |
| 2.20 | 90 days | 15.86 | close to zero percent |
Based on a normal probability distribution, the odds of MAIA Biotechnology to move over $ 15.86 or more in 90 days from now is close to zero percent (This MAIA Biotechnology probability density function shows the probability of MAIA Stock to fall within a particular range of prices over 90 days) . Probability of MAIA Biotechnology price to stay between its current price of $ 2.20 and $ 15.86 at the end of the 90-day period is about 92.1 .
Given the investment horizon of 90 days MAIA Biotechnology has a beta of 0.66. This indicates as returns on the market go up, MAIA Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding MAIA Biotechnology will be expected to be much smaller as well. Additionally MAIA Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. MAIA Biotechnology Price Density |
| Price |
Predictive Modules for MAIA Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MAIA Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MAIA Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MAIA Biotechnology is not an exception. The market had few large corrections towards the MAIA Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MAIA Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MAIA Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.44 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 0.34 | |
Ir | Information ratio | -0.1 |
MAIA Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MAIA Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MAIA Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MAIA Biotechnology generated a negative expected return over the last 90 days | |
| MAIA Biotechnology has high historical volatility and very poor performance | |
| MAIA Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MAIA Biotechnology currently holds about 8.15 M in cash with (13.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| MAIA Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer |
MAIA Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MAIA Stock often depends not only on the future outlook of the current and potential MAIA Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MAIA Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.3 M | |
| Cash And Short Term Investments | 7.2 M | |
| Shares Float | 19.5 M |
MAIA Biotechnology Technical Analysis
MAIA Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. MAIA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MAIA Biotechnology. In general, you should focus on analyzing MAIA Stock price patterns and their correlations with different microeconomic environments and drivers.
MAIA Biotechnology Predictive Forecast Models
MAIA Biotechnology's time-series forecasting models is one of many MAIA Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MAIA Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about MAIA Biotechnology
Checking the ongoing alerts about MAIA Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MAIA Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MAIA Biotechnology generated a negative expected return over the last 90 days | |
| MAIA Biotechnology has high historical volatility and very poor performance | |
| MAIA Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MAIA Biotechnology currently holds about 8.15 M in cash with (13.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
| MAIA Biotechnology has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer |
Check out MAIA Biotechnology Backtesting, MAIA Biotechnology Valuation, MAIA Biotechnology Correlation, MAIA Biotechnology Hype Analysis, MAIA Biotechnology Volatility, MAIA Biotechnology History as well as MAIA Biotechnology Performance. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Return On Assets (1.07) | Return On Equity (5.60) |
The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.